Trial Profile
A single-center, prospective registry study to evaluate the impact of prasugrel and high-dose clopidogrel in patients with acute coronary syndrome.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Dec 2015
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 29 Dec 2015 New trial record